{"id":11351,"date":"2020-09-04T13:52:12","date_gmt":"2020-09-04T18:52:12","guid":{"rendered":"https:\/\/www.billingparadise.com\/blog\/?p=11351"},"modified":"2026-03-11T02:14:36","modified_gmt":"2026-03-11T07:14:36","slug":"the-right-healthcare-for-cvd-patients-infographic","status":"publish","type":"post","link":"https:\/\/www.billingparadise.com\/blog\/the-right-healthcare-for-cvd-patients-infographic\/","title":{"rendered":"The Right Healthcare for CVD Patients – Infographic"},"content":{"rendered":"

COVID-19 is perhaps the deadliest pandemic we have ever faced. But there is another illness that has consistently killed people year after year long before COVID-19. That deadly illness is Cardiovascular Diseases (CVD). Researchers and health experts say that annually an approximate of 18 million people around the world die from CVD. Which roughly equates to about 300 million life-years lost and a further 35 million years lived succumbed to harrowing disability due to CVD. The brutal fact is that these numbers only reflect the grim situation of the present, in the future it is said to be much worse. It is projected that by 2050, due to the high population one in sex adults will\u00a0 be around or more than 65 (in the age group most prone to CVD) and that it will get much worse for low & middle-income countries, which is major portion of the world and not to mention were over 80% of death occur.\u00a0<\/span><\/p>\n

So there is no clear solution to reducing the chances of CVD, it is worse now and is projected to get consistently worse over time. However, we can ensure that the patients get quality treatment and holistic treatment that allows the patient to recover in a more profound manner and ensure that their quality of life improves.\u00a0<\/span><\/p>\n

A sure way to ensure that patients get the care they require in a way that is possible for physicians to deliver, the healthcare system needs to approach for a more data-driven solution. Data collected from patients and physicians can help us in getting a clear picture of what needs to be done to improve treatment and care for CVD patients and that is exactly what Beyond Intervention has done.\u00a0\u00a0<\/span><\/p>\n

Abbott Laboratories<\/span> is an American multinational medical device and healthcare company that recently conducted a study dubbed as <\/span>Beyond Intervention<\/span><\/a> and this infographic is based on the results and findings of that study. The main purpose of this study was to show people that using advanced technologies can enable more precise diagnoses and better treatment strategies\u202fto ensure the best\u202fpossible results.\u00a0 The survey was designed to examine the current state of vascular care and how health care leaders, physicians and patients view the importance of incorporating data and technology into treatment pathways. Which the study has accomplished to a T.\u00a0<\/span><\/p>\n

For the study, 1,432 physicians, health system administrators and patients from December 2019 through January 2020 to understand the effect of advancements in cardiovascular technology on patient care. Respondents to the online survey represent nine countries: The United States, United Kingdom, China, Japan, France, Germany, India, Italy and Brazil. Now data collected from all these responses were analysed and here is the infographic depicting the final product<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/section>

[vc_single_image image=”11361″ img_size=”full” alignment=”center”]<\/div><\/div><\/section>
[vc_custom_heading text=”The following key details were concluded from the study:” font_container=”tag:h2|font_size:23px|text_align:left|line_height:1.5″ google_fonts=”font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal”]